CLDI

CLDI

USD

Calidi Biotherapeutics Inc. Common Stock

$1.500+0.010 (0.671%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.490

High

$1.540

Low

$1.480

Volume

0.07M

Company Fundamentals

Market Cap

8.0M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.26M

Exchange

ASE

Currency

USD

52-Week Range

Low $1.41Current $1.500High $46.68

Related News

GlobeNewswire

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted

View more
Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting